Original Research Articles

Homocysteine a non-conventional risk factor for vasculopathic patients

Sunil Agarwal Assistant Professor, Department of Medicine, MIMER Medical College, Talegaon, Pune, Maharashtra, India Deepak Kamat Associate Professor, Obstetrics & Gynaecology, Rural Medical College, PIMS (D.U.), Maharashtra, India Pooja Shah Resident, Orthodontics & Dentofacial Orthopaedics, Rural Dental College, PIMS (D.U.), Loni, Maharashtra, India Rahul Kunkulol Professor, Department of Pharmacology, Rural Medical College, PIMS (D.U.), Loni, Maharashtra, India
Published: 2021-12-13
107 Views
120 Downloads

Abstract

Research is underway and many other factors are being identified, including homocysteine (Hcy). Since 1990, there has been an exponential increase in the number of publications on Hcy and coronary artery disease, suggesting elevated plasma Hcy as an independent risk factor. As a result, this study was conducted to determine the prevalence of a new risk factor (homocysteine) in the general population (both young and old), as well as any differences in prevalence rates (if any) between young (less than 45 years of age) and elderly (more than 45 years of age) patients with vasculopathy. This was a case control study done in the cardiology unit of Bharti Hospital, Pune. All the patients diagnosed as cases of vasculopathies, especially IHD/Stroke/DVT (n =75) were enrolled as cases for the study, and healthy volunteers of the same age and gender matched (n =75) were enrolled as controls and subjected to the following inclusion and exclusion criteria. All cases and controls were assessed for their homocysteine level on day 0 of admission by using the MEIA/FPIA Technique on IMX, Abbott, USA. The mean homocysteine level was 23.2499 (12.2739) in cases vs. 13.24 (3.0912) in controls, with a statistically significant ‘p’ value by unpaired ‘t’ and Mann-Whitney statistics. Elevated Hcy levels above 15 mol/l were detected in 70% of cases and 22% of controls, respectively. On comparing homocysteine to individual vasculopathy, it was found that homocysteine was a more significant risk factor in IHD > stroke >DVT.

Keywords

Homocysteine; Vasculopathy; Ischaemic heart disease; Stroke; Deep vein thrombosis; Risk Factor

Download

PDF

How to Cite

Agarwal, S. ., Kamat, D. ., Shah, P. ., & Kunkulol, R. . (2021). Homocysteine a non-conventional risk factor for vasculopathic patients. International Journal of Clinical and Biomedical Research, 7(4), 6–9. Retrieved from https://sumathipublications.com/index.php/ijcbr/article/view/427

Downloads

Download data is not yet available.
Published In: Volume 7, Issue 4; 2021
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Similar Articles

<< < 1 2 3 4 5 6 7 8 9 10 11 12 > >> 

You may also start an advanced similarity search for this article.